A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

被引：0

作者：

Mark E Robson

Pierre O Chappuis

Jaya Satagopan

Nora Wong

Jeff Boyd

John R Goffin

Clifford Hudis

David Roberge

Larry Norton

Louis R Bégin

Kenneth Offit

William D Foulkes

机构：

[1] Memorial Sloan-Kettering Cancer Center,Department of Medicine

[2] Cancer Prevention Centre,Research Institute of McGill University Health Centre

[3] McGill University,Department of Epidemiology/Biostatistics

[4] Memorial Sloan-Kettering Cancer Center,Cancer Prevention Centre, Sir Mortimer B Davis

[5] McGill University,Jewish General Hospital

[6] Memorial Sloan-Kettering Cancer Center,Department of Surgery

[7] McGill University,Department of Oncology

[8] McGill University,Department of Pathology

[9] McGill University,Program in Cancer Genetics, Departments of Oncology and Human Genetics

[10] University Hospitals of Geneva,Divisions of Oncology and Medical Genetics

[11] Hôpital du Sacré-Coeur de Montréal,Division of Hematology/Oncology, Department of Medicine

[12] Tufts University,undefined

[13] Tufts University-New England Medical Center,undefined

来源：

Breast Cancer Research | / 6卷

关键词：

adjuvant therapy; breast cancer; contralateral; ipsilateral; prognosis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Outcomes after breast cancer in an ethnically diverse cohort of high-risk patients: Differences in survival based on BRCA1/BRCA2 mutation status
Nanda, R.
Huo, D.
Cook, M.
Chen, L.
Hope, K.
Cummings, S.
Olopade, O. I.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[42] Initiation, evolution, phenotype and outcome of BRCA1 and BRCA2 mutation-associated breast cancer
Yu, Ke-Da
Shao, Zhi-Ming
NATURE REVIEWS CANCER, 2012, 12 (05) : 372 - U67
[43] Initiation, evolution, phenotype and outcome of BRCA1 and BRCA2 mutation-associated breast cancer
Ke-Da Yu
Zhi-Ming Shao
Nature Reviews Cancer, 2012, 12 : 372 - 373
[44] The impact of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers.
Metcalfe, Kelly A.
Lynch, Henry T.
Snyder, Carrie L.
Foulkes, William
Tung, Nadine M.
Kim-Sing, Charmaine
Olopade, Olufunmilayo I.
Eisen, Andrea
Rosen, Barry
Sun, Ping
Narod, Steven
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[45] The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation
Adriana Valentini
Jan Lubinski
Tomasz Byrski
Parviz Ghadirian
Pal Moller
Henry T. Lynch
Peter Ainsworth
Susan L. Neuhausen
Jeffrey Weitzel
Christian F. Singer
Olufunmilayo I. Olopade
Howard Saal
Dominique Stoppa Lyonnet
William D. Foulkes
Charmaine Kim-Sing
Siranoush Manoukian
Dana Zakalik
Susan Armel
Leigha Senter
Charis Eng
Eva Grunfeld
Anna M. Chiarelli
Aletta Poll
Ping Sun
Steven A. Narod
Breast Cancer Research and Treatment, 2013, 142 : 177 - 185
[46] BRCA1 and BRCA2 Mutations and Breast Cancer
Narod, Steven A.
Salmena, Leonardo
DISCOVERY MEDICINE, 2011, 12 (66) : 445 - 453
[47] BRCA1 and BRCA2 in hereditary breast cancer
Scully, R
Puget, N
BIOCHIMIE, 2002, 84 (01) : 95 - 102
[48] The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation
Valentini, Adriana
Lubinski, Jan
Byrski, Tomasz
Ghadirian, Parviz
Moller, Pal
Lynch, Henry T.
Ainsworth, Peter
Neuhausen, Susan L.
Weitzel, Jeffrey
Singer, Christian F.
Olopade, Olufunmilayo I.
Saal, Howard
Lyonnet, Dominique Stoppa
Foulkes, William D.
Kim-Sing, Charmaine
Manoukian, Siranoush
Zakalik, Dana
Armel, Susan
Senter, Leigha
Eng, Charis
Grunfeld, Eva
Chiarelli, Anna M.
Poll, Aletta
Sun, Ping
Narod, Steven A.
BREAST CANCER RESEARCH AND TREATMENT, 2013, 142 (01) : 177 - 185
[49] BRCA2 AND BRCA1 breast cancer phenotypes
Marcus, JN
Watson, P
Page, DL
Narod, SA
Tonin, P
Serova, O
Lenoir, GM
Lynch, HT
LABORATORY INVESTIGATION, 1997, 76 (01) : 110 - 110
[50] Predicting the probability of BRCA1 and BRCA2 mutation carrier status in young women with breast cancer
Lilla, M.
Zsuzsa, B.
Janina, K.
HISTOPATHOLOGY, 2008, 53 : 48 - 48

← 1 2 3 4 5 →